Pi-Cardia

Following the successful completion of our Global ShortCut Pivitol study, we are absolutely thrilled to announce the launch of our Continued Access study for ShortCut in the U.S. 🚀 A huge shoutout to Dr. Saibal Kar, Dr. Gregory P. Fontana, MD, FACC, FACS, and the amazing team at 🏥 Los Robles Hospital and Medical Center for kicking off this new chapter. They performed the first two ShortCut cases in the study on patients with very challenging anatomies, including failed Trifecta and Magna Ease valves at risk of coronary obstruction. Both patients were treated successfully with a dual leaflet split using the ShortCut device, enabling a safe TAVR. This expansion of our clinical program allows us to gather even more valuable insights. Here’s to reaching more patients and making a difference! ✨ . . . Pi-Cardia Eric Cheek Gary Gratson Christoph Lesser Hardip Thakerar #PiCardia #ShortCut #TAVI #TAVR #AorticValve #AorticStenosis #ValveinValve #VIV #Innovation #StructuralHeart #LifetimeManagement #LifetimeManagementofAS #percutaneoustreatment #transcatheter #leafletsplitting #medtech #startuphealth #coronaryobstruction #coronaryaccess #leafletmodification #valvefailure #mechanicalsplitting #valves #TAVRenabler #Splitwithconfidence #ShortCutPivotalStudy #ShortCutCAS

#SWAC TONIGHT: ShortCut vs BASILICA Join us for SWAC tonight @5pm PST/8pm EST for an informative data update on one of the most exciting tools in the SHD community for TAVR facilitatation during VIV deployment! We have guest co-moderators Drs. Philippe Genereaux and Susheel Kodali discussing unmet clinical needs and what the space looks like in the next 10-years! #Shortcut Philippe Généreux Kodali Susheel Tucson Medical Center https://lnkd.in/ghE-SvCz

Leaflet modification is key for the lifetime management of patients requiring multiple valve interventions 🫀 ✅ Annual ViV is projected to reach ~42k US procedures in 2035 (~15% of all TAVR). ✅ With increased TAVR usage, total annual TAVR-in-TAVR is expected to overtake TAVR-in-SAVR by 2028. Congratulations to the authors on this important article! 👏 https://lnkd.in/du6vHPmJ Philippe Généreux Roy Dar Rishi Puri Yoseph Rozenman Molly Szerlip Pradeep Yadav Vinod Thourani Philippe Pibarot Danny Dvir Susheel Kodali Didier Tchetche Benjamin Seguy Paolo Denti Saibal Kar Ulrich Gerckens Medtronic Cardiac and Vascular Edwards Surgical Structural Heart Therapies Abbott | Cardiovascular Boston Scientific Cardiology CRF PCR #PiCardia #ShortCut #TAVI #TAVR #AorticValve #AorticStenosis #ValveinValve #VIV #Innovation #StructuralHeart #LifetimeManagement #LifetimeManagementofAS #percutaneoustreatment #transcatheter #leafletsplitting #medtech #startuphealth #coronaryobstruction #coronaryaccess #leafletmodification #valvefailure #mechanicalsplitting #valves

With an expected rise in redo TAVI and valve-in-valve procedures, there is heightened interest in technologies that can help to facilitate coronary access and prevent obstruction resulting from the treatment. At PCR London Valves, Didier Tchetche presented details of the ShortCut pivotal trial, outlining details of one such device aimed at addressing this need.

Happy 4th of July! Wishing everyone a safe and joyful holiday! #IndependenceDay #Happy4thofJuly

#ShortCut addresses an unmet need and will be important for the lifetime management of patients requiring multiple valve interventions. ✅60 pts treated with failed bioprosthetic valves at risk for coronary obstruction (single split 63% and dual split 37%).  ✅Leaflet splitting with ShortCut met the primary safety endpoints, with 0% procedural mortality and 1.7% stroke. ✅Primary efficacy endpoint of successful leaflet splitting was achieved in 100% of pts. ✅Leaflet split achieved efficiently with a single attempt in all cases, despite being performed by first time users (no roll-in subjects). . . . Pi-Cardia #PiCardia #TAVI #TAVR #AorticValve #AorticStenosis #ValveinValve #VIV #Innovation #StructuralHeart #LifetimeManagement #LifetimeManagementofAS #percutaneoustreatment #transcatheter #leafletsplitting #nextfrontier #medtech #startuphealth #coronaryobstruction #coronaryaccess #leafletmodification #valvefailure #mechanicalsplitting

Interventions for valvular disease: Highlights of #EuroPCR 2024 Chris Cook hosts Nicolas Dumonteil and Bernard Prendergast as they discuss amongst others: 🟣 record-breaking abstracts and cases, demonstrating expertise in #TAVI, #mitral, and #tricuspid procedures 🟣 LIVE cases, especially in complex TAVI scenarios, reflecting everyday practice 🟣 the crucial role of #imaging in patient selection and procedure guidance 🟣 key studies like NOTION-II and LANDMARK, and the groundbreaking ShortCut trial addressing degenerated aortic bioprostheses, and much more! https://lnkd.in/duCEPVxm

A remarkable week at #NYValves2024 as the excitement around #ShortCut continues! 🚀 A heartfelt thanks to our key experts on their excellent presentations showcasing the true innovation in leaflet modification. 👏 . . . Cardiovascular Research Foundation Philippe Généreux Philippe Pibarot Susheel Kodali #PiCardia #ShortCut #TAVI #TAVR #AorticValve #AorticStenosis #ValveinValve #VIV #Innovation #StructuralHeart #LifetimeManagement #LifetimeManagementofAS #percutaneoustreatment #transcatheter #leafletsplitting #nextfrontier #medtech #startuphealth #coronaryobstruction #coronaryaccess #leafletmodification  #valvefailure #mechanicalsplitting 

Congratulation to all co-authors! TAVR-in-TAVR will represent ~15% (>42,000) of all TAVR procedures perform in 2035. Let’s get ready!

📢 Accepted for publication in Structural Heart and presented today at #NYValves2024! Dr. Philippe Généreux unveils a proposed model for predicting treatment of bioprosthetic aortic valve failure in the U.S. 🫀 #cardiology #interventionalcardiology